H-2DP transgene alters natural killer cell specificity at the target and effector cell levels: Comparison with an H-2Dd transgene

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2423-2429

  Sentman, Charles L ^a,c   Olsson Alheim, Mats Y ^a   Lendahl, Urban ^b   Kärre, Klas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN H 2D(B); HISTOCOMPATIBILITY ANTIGEN H-2D(B); MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CANCER TRANSPLANTATION; CLASSIFICATION; COMPARATIVE STUDY; CYTOLOGY; CYTOTOXICITY; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; GRAFT REJECTION; IMMUNOLOGY; IN VITRO STUDY; MALE; MOUSE; NATURAL KILLER CELL; TRANSGENIC MOUSE; ANIMAL CELL; CELL SPECIFICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

ANIMALS; BONE MARROW TRANSPLANTATION; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; H-2 ANTIGENS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029664425     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. - bone marrow in chimeric mice. Proc. Natl. Acad. Sci. USA 88:10332.
2. Liao, N.-S., M. Bix, M. Zijstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 233:199.
3. Kärre, K., H.-G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggest alternative immune defense strategy. Nature 319:675.
4. Chadwick, B. S., and R. G. Miller. 1992. Hybrid resistance in vitro: possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J. Immunol. 148:2307.
5. Sentman, C. L., M. Y. Olsson, M. Salcedo, P. Höglund, U. Lendahl, and K. Kärre. 1994. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets: protection mediated by αl/α2 domains. J. Immunol. 153:5482.
6. Ljunggren, H.-G., and K. Kärre. 1990. In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11:7.
7. Kärre, K. 1985. Role of target histocompatibility antigens in regulation of natural killer activity, a reevaluation and a hypothesis. In Mechanisms of Cytotoxicity by NK Cells. R. B. Herberman and D. M. Callawaert, eds., Academic Press, New York, p. 81.
8. Yokoyama, W. M., and W. B. Seaman. 1993. The Ly-49 and NKR-P1 gene families encoding lectin like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11:613.
9. Smith, H. R. C., F. M. Karlhofer, and W. M. Yokoyama. 1994. Ly-49 multigene family expressed by IL-2-activated NK cells. J. Immunol. 153:1068.
10. Kane, K. P. 1994. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J. Exp. Med. 179:1011.
11. Daniels, B. F., F. M. Karlhofer, W. E. Seaman, and W. M. Yokoyama. 1994. A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J. Exp. Med. 180:687.
12. Brennan, J., D. Mager, W. Jeffries, and F. Takei. 1994. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 180:2287.
13. + IL-2-activated natural killer cells. Nature 358: 66.
14. Ohlen, C., G. Kling, P. Höglund, M. Hansson, G. Scangos, C. Bieberich, G. Jay, and K. Kärre. 1989. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 246:666.
15. d transgene to C57BL/6 mice. J. Exp. Med. 168:1469.
16. Rembecki, R. M., V. Kumar, C. S. David, and M. Bennett. 1988. Polymorphism of Hh-1, the mouse hemopoietic histocompatibility locus. Immunogenetics 28: 158.
17. Bennett, M. 1987. Biology and genetics of hybrid resistance. Adv. Immunol. 41:333.
18. Colonna, M., E. G. Brooks, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260:1121.
19. Ciccone, E., D. Pende, M. Vitale, L. Nanni, C. Di Donato, C. Bottino, L. Morelli, O. Viale, A. Amoroso, A. Moretta, and L. Moretta. 1994. Self class I molecules protect normal cells from lysis mediated by autologous killer cells. Eur. J. Immunol. 234:1003.
20. Litwin, V., J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier. 1993. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and nonself alleles, and influence of the target cell type. J. Exp. Med. 178:1321.
21. P gene. Immunogenetics 19:195.
22. Nilsson, E., and U. Lendahl. 1993. Transient expression of a human β-actin promoter/lacZ gene introduced into mouse embryos correlates with a low degree of methylation. Mol. Reprod. Dev. 34:149.
23. b bone marrow grafts. J. Exp. Med. 170:191.
24. f. Eur. J. Immunol. 21:2821.
25. Glas, R., M. Waldenström, P. Höglund, G. Klein, K. Kärre, and H.-G. Ljunggren. 1995. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex class I expression on the graft. Cancer Res. 55:1911.
26. Olsson, M. Y., K. Kärre, and C. L. Sentman. 1995. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc. Natl. Acad. Sci. USA 92: 1649.
27. k loci: evolutionary relationships to H-2 genes from four other mouse strains. J. Immunol. 139:3878.
28. Pullen, J. K., R. M. Horton, Z. Cai, and L. R. Pease. 1992. Structural diversity of the classical H-2 genes: K, D, and L. J. Immunol 148:953.
29. Storkus, W. J., J. Alexander, J. A. Payne, P. Cresswell, and J. R. Dawson. 1989. The α1/α2 domains of class I HLA molecules confer resistance to natural killing. J. Immunol. 143:3853.
30. Shirai, M., M. S. Vacchio, R. J. Hodes, and J. A. Berzofsky. 1993. Preferential Vβ usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction. J. Immunol. 151:2283.
31. Karlhofer, F. M., R. Hunziker, A. Reichlin, D. Marguiles, and W. M. Yokoyama. 1994. Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J. Immunol. 153:2407.
32. r molecules expressed on bone marrow cells. Int. Immunol. 6:1297.
33. Afifi, M. S., V. Kumar, and M. Bennett. 1985. Stimulation of genetic resistance to marrow grafts in mice by imerferon-α/β. J. Immunol. 134:3739.